A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1038/s41598-024-62917-z
Published Online: 2024-05-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Shanshan
Liu, Zhengcao
Chen, Qingqing
Chen, Yuetong
Ji, Shengjun
Text and Data Mining valid from 2024-05-30
Version of Record valid from 2024-05-30
Article History
Received: 4 March 2024
Accepted: 22 May 2024
First Online: 30 May 2024
Competing interests
: The authors declare no competing interests.